Stock of the Day

June 16, 2020

Teleflex (TFX)

$134.96
-$0.26 (-0.2%)
Market Cap: $5.99B

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. It also offers interventional products, which consists of various coronary catheters, structural heart support devices, and peripheral intervention and mechanical circulatory support platform that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded pumps and catheters, Guideline, Turnpike, and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices. The company provides anesthesia products, such as airway and pain management products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligation clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. It also offers interventional urology products comprising the UroLift System, an invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia; respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings; urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology; and bladder management services. The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets. Teleflex Incorporated was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.

Today's Trend

Teleflex Incorporated (NYSE: TFX) shares are getting support from a combination of solid Q1 results and bullish analyst ratings, but the stock is also facing pressure from a wave of lower long-term earnings estimates.

  • Teleflex beat first-quarter earnings and revenue expectations, which signals that near-term business performance is still holding up better than expected, even as the market digests margin pressure. TFX Stock Down Post Q1 Earnings & Revenue Beat, Margins Crash
  • Needham & Company reiterated a Buy rating and a $147 price target, suggesting confidence that Teleflex can deliver meaningful earnings growth over the next several years.
  • The company’s latest earnings outlook still implies growth from the current year to FY2027 and FY2028, which may help support investor sentiment despite the recent reset in estimates.
  • Analysts at Citizens JMP and Needham released mostly constructive but varied quarterly projections for FY2026 and FY2027, indicating that expectations remain in flux following the earnings report.
  • Wolfe Research lowered Teleflex’s FY2026, FY2027, FY2028, FY2029 and FY2030 EPS estimates, reflecting a more cautious view on the company’s longer-term earnings trajectory.
  • The post-earnings reaction was hurt by steep margin declines and a 52.1% drop in operating profit, which raised concerns that revenue growth is not yet translating into strong profitability. TFX Stock Down Post Q1 Earnings & Revenue Beat, Margins Crash

Overall, TFX appears to be trading on a tug-of-war between strong near-term results and buy-rated optimism on one hand, and margin weakness plus reduced long-term earnings estimates on the other. The stock has been up recently, but the latest analyst revisions suggest investors are still debating how durable Teleflex’s profit recovery will be.

← Previous Stock of the DayNext Stock of the Day →